Tuesday, November 24th | 9 Kislev 5781

Subscribe
May 27, 2020 9:31 am

Report: Mossad Chief’s Covert Connections Instrumental in War on COVID-19

avatar by JNS.org

Mossad chief Yossi Cohen speaks at a Cyber Week at Tel Aviv University on June 24, 2019. Photo: Flash90.

JNS.org – Israeli intelligence agency Mossad Director Yossi Cohen used his international connections—some covert—to procure massive amounts of medical equipment and protective gear as part of the government’s efforts to compete in the global bidding war for supplies to contain COVID-19, Israeli media reported on Wednesday.

Among these connections are Persian Gulf countries with no diplomatic ties with Israel, according to a report by Ynet.

Since the onset of the coronavirus outbreak, the report said, Cohen has managed to purchase 2.5 million protective goggles (with an additional 5.5 million on the way); approximately 80 million simple surgical masks (with an additional 142 million on the way) and 1.3 million N-95 masks (with an additional 14 million on the way); 180 million latex gloves; more than 30 tons of disinfectant; some 1,300 ventilators (with another 4,700 on the way); 4 million protective vests; and more than 2 million COVID-19 test kits, most of which are from China and South Korea.

For the past few days, the Mossad has been in the process of transferring responsibility for procurement of anti-coronavirus equipment to the Health Ministry, which reportedly will receive 3,500 Israeli-made ventilators within the next few weeks, and another 10,000 by October.

Related coverage

November 24, 2020 11:48 am
0

New Innovative Vaccines Are Safe, Says Top Israeli Virologist

CTech - Coronavirus has wreaked havoc on the world for most of the past year, but new vaccines developed by...

During a meeting with Cohen on Sunday—ahead of the transfer of operations to the Health Ministry, Israeli Prime Minister Benjamin Netanyahu thanked him and the Mossad for having done “something extraordinary.”

“The results speak for themselves,” Netanyahu said.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.